China SXT Pharmaceuticals, Inc. Announces Share Re-classification
Globe Newswire (Mon, 23-Mar 9:00 AM ET)
SXTC to Execute 1-for-150 Share Consolidation: What This Means for Investors
Market Chameleon (Mon, 2-Feb 4:53 AM ET)
Market Chameleon (Thu, 8-Jan 5:30 AM ET)
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
China Sxt Pharmaceuticals - Class A trades on the NASDAQ stock market under the symbol SXTC.
As of June 12, 2026, SXTC stock price climbed to $2.57 with 150,443 million shares trading.
SXTC has a beta of 0.76, meaning it tends to be less sensitive to market movements. SXTC has a correlation of 0.00 to the broad based SPY ETF.
SXTC has a market cap of $11.46 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, SXTC traded as high as $1,406.25 and as low as $1.25.
SXTC has underperformed the market in the last year with a return of -99.1%, while SPY returned +24.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in SXTC shares. However, SXTC has outperformed the market in the last 3 month and 2 week periods, returning +18.4% and +64.7%, while SPY returned +9.9% and -1.7%, respectively. This indicates SXTC has been having a stronger performance recently.
SXTC support price is $2.07 and resistance is $2.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SXTC shares will trade within this expected range on the day.
